Community Hospital of Anaconda

Community Hospital of Anaconda was paid $1.09M by Medicaid between Jan 2018 and Dec 2024, across 170 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 23% of everything it billed.

Box 24A · Dates of service

Paid by month

Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider

By year, as a table

Year	Claims	Paid
2018	44,084	$198K
2019	40,282	$196K
2020	30,242	$88K
2021	42,030	$170K
2022	46,934	$187K
2023	47,035	$146K
2024incomplete	31,566	$105K

Box 24 · Service lines

What it billed for

Code	Service	Share	Claims	Bene. records	Paid
99213	Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity	23%	18,418	13,491	$247K
99283	Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity	10%	6,269	5,181	$112K
99284	Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity	9.9%	5,827	4,298	$108K
74177	Computed tomography, abdomen and pelvis; with contrast material	5.2%	1,196	1,016	$56K
99285	Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life	4.0%	3,843	2,507	$44K
G0378	Hospital observation service, per hour	3.8%	984	759	$42K
80053	Comprehensive metabolic panel	3.3%	16,608	13,629	$36K
92507	Treatment of speech, language, voice, communication, and/or auditory processing disorder	3.1%	3,919	1,203	$34K
99214	Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity	2.3%	10,007	5,749	$25K
87502	Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets	2.2%	2,551	2,325	$24K
70450	Computed tomography, head or brain; without contrast material	1.7%	917	746	$18K
87651	Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe	1.6%	3,316	3,113	$17K

158 more codes

71046	Radiologic examination, chest; 2 views	1.6%	2,907	$17K
87635	Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe	1.4%	4,707	$15K
97110	Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion	1.3%	6,619	$14K
85025	Blood count; complete (CBC), automated, and automated differential WBC count	1.3%	17,698	$14K
90686		1.2%	1,704	$13K
90715		1.0%	1,085	$11K
96361	Intravenous infusion, hydration; each additional hour	1.0%	2,627	$11K
96365	Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour	<1%	2,764	$11K
U0003	Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r	<1%	1,881	$11K
36415	Collection of venous blood by venipuncture	<1%	24,967	$9K
87804	Infectious agent antigen detection by immunoassay; Influenza, each type	<1%	988	$9K
96375	Therapeutic injection; each additional sequential IV push	<1%	3,413	$9K
96372	Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular	<1%	4,381	$8K
80307	Drug test(s), presumptive, any number of drug classes; immunoassay	<1%	888	$8K
93005	Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report	<1%	3,849	$8K
96374	Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance	<1%	3,157	$7K
97530	Therapeutic activities, direct patient contact, each 15 minutes	<1%	1,109	$7K
87880	Infectious agent antigen detection by immunoassay; Streptococcus, group A	<1%	1,496	$7K
97140	Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage)	<1%	4,848	$6K
81001		<1%	4,367	$6K
84443	Thyroid stimulating hormone (TSH)	<1%	7,389	$6K
80061	Lipid panel	<1%	4,229	$5K
86140		<1%	2,616	$5K
83036	Hemoglobin; glycosylated (A1C)	<1%	4,418	$5K
87081		<1%	1,076	$5K
99212	Office or other outpatient visit for the evaluation and management of an established patient, straightforward	<1%	2,684	$5K
J7030	Infusion, normal saline solution , 1000 cc	<1%	4,376	$5K
J1050	Injection, medroxyprogesterone acetate, 1 mg	<1%	584	$4K
80048	Basic metabolic panel (calcium, ionized)	<1%	2,522	$4K
J1100	Injection, dexamethasone sodium phosphate, 1 mg	<1%	3,618	$4K
84439		<1%	2,052	$4K
81025		<1%	2,759	$4K
87186		<1%	1,030	$3K
83690		<1%	2,841	$3K
J7120	Ringers lactate infusion, up to 1000 cc	<1%	4,493	$3K
87420		<1%	247	$3K
90651		<1%	18	$3K
83605		<1%	2,489	$3K
87086	Culture, bacterial; quantitative colony count, urine	<1%	2,667	$3K
83655		<1%	357	$3K
99282	Emergency department visit for the evaluation and management, low to moderate severity	<1%	659	$3K
87491	Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe	<1%	591	$3K
73562		<1%	430	$2K
82306	Vitamin D; 25 hydroxy, includes fraction(s), if performed	<1%	1,659	$2K
J2704	Injection, propofol, 10 mg	<1%	3,286	$2K
87591	Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe	<1%	607	$2K
87798	Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism	<1%	66	$2K
J7050	Infusion, normal saline solution, 250 cc	<1%	3,399	$2K
90656		<1%	116	$2K
U0005	Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2	<1%	1,051	$1K
94640	Pressurized or nonpressurized inhalation treatment for acute airway obstruction	<1%	411	$1K
91320		<1%	51	$1K
84703		<1%	1,024	$1K
81003		<1%	1,903	$1K
J2001	Injection, lidocaine hcl for intravenous infusion, 10 mg	<1%	3,238	$1K
84484		<1%	2,429	$1K
82728		<1%	281	$992.83
85651		<1%	593	$981.26
96360	Intravenous infusion, hydration; initial, 31 minutes to 1 hour	<1%	555	$943.00
73030		<1%	228	$903.97
87077		<1%	1,058	$802.17
J0690	Injection, cefazolin sodium, 500 mg	<1%	1,420	$792.06
73610		<1%	144	$777.99
85018		<1%	612	$743.11
J2405	Injection, ondansetron hydrochloride, per 1 mg	<1%	3,965	$699.15
85379		<1%	572	$678.10
85027		<1%	1,603	$605.55
90480		<1%	34	$585.87
83540		<1%	303	$575.00
J3490	Unclassified drugs	<1%	1,175	$562.78
83735		<1%	2,136	$558.60
90670		<1%	14	$554.22
J3010	Injection, fentanyl citrate, 0.1 mg	<1%	2,819	$550.01
80305		<1%	350	$523.24
73110		<1%	77	$487.47
71045	Radiologic examination, chest; single view	<1%	555	$481.92
81002		<1%	1,835	$440.61
J0696	Injection, ceftriaxone sodium, per 250 mg	<1%	249	$414.98
80178		<1%	133	$400.55
J1885	Injection, ketorolac tromethamine, per 15 mg	<1%	2,617	$375.64
36416		<1%	146	$332.66
85610		<1%	2,923	$325.07
73630		<1%	60	$313.82
80076		<1%	65	$312.38
83550		<1%	158	$278.79
87811	Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19)	<1%	84	$274.38
88305	Level IV - Surgical pathology, gross and microscopic examination	<1%	675	$268.50
96376		<1%	43	$236.12
J2250	Injection, midazolam hydrochloride, per 1 mg	<1%	1,587	$209.38
90682		<1%	257	$166.74
87070		<1%	47	$161.33
83615		<1%	194	$158.51
91322		<1%	47	$146.63
97161		<1%	14	$133.55
87040		<1%	19	$130.48
J1170	Injection, hydromorphone, up to 4 mg	<1%	1,196	$104.65
87807		<1%	20	$103.27
99152		<1%	37	$72.41
Q9967	Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml	<1%	404	$68.00
J2270	Injection, morphine sulfate, up to 10 mg	<1%	186	$67.15
J0131	Injection, acetaminophen, not otherwise specified,10 mg	<1%	45	$65.53
87147		<1%	13	$63.56
G0008	Administration of influenza virus vaccine	<1%	139	$45.30
82570		<1%	180	$45.22
J0665	Injection, bupivicaine, not otherwise specified, 0.5 mg	<1%	269	$42.30
87205		<1%	15	$42.24
93010	Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only	<1%	496	$33.40
J7613	Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg	<1%	171	$29.50
J2550	Injection, promethazine hcl, up to 50 mg	<1%	84	$9.45
82607		0%	32	$0.00
A9270	Non-covered item or service	0%	1,456	$0.00
86901		0%	449	$0.00
86850		0%	632	$0.00
G0283	Electrical stimulation (unattended), to one or more areas for indication(s) other than wound care, as part of a therapy plan of care	0%	150	$0.00
97162		0%	129	$0.00
82077		0%	22	$0.00
90471	Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine	0%	17	$0.00
J7620	Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme	0%	51	$0.00
77063	Screening digital breast tomosynthesis, bilateral	0%	83	$0.00
90732		0%	13	$0.00
97112	Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination	0%	163	$0.00
G0439	Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit	0%	65	$0.00
82043		0%	83	$0.00
82962		0%	206	$0.00
83880		0%	83	$0.00
73502		0%	18	$0.00
Q3014	Telehealth originating site facility fee	0%	28	$0.00
82550		0%	33	$0.00
90673		0%	12	$0.00
90677		0%	28	$0.00
J1040	Injection, methylprednisolone acetate, 80 mg	0%	15	$0.00
71275	Computed tomographic angiography, chest, with contrast material	0%	15	$0.00
J7999	Compounded drug, not otherwise classified	0%	14	$0.00
86703		0%	409	$0.00
77067	Screening mammography, bilateral, including computer-aided detection	0%	95	$0.00
84100		0%	95	$0.00
72100		0%	57	$0.00
86900		0%	440	$0.00
94729		0%	13	$0.00
99211	Office or other outpatient visit for the evaluation and management of an established patient, minimal severity	0%	1,061	$0.00
99391	Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year)	0%	48	$0.00
72110		0%	101	$0.00
82977		0%	70	$0.00
99442		0%	30	$0.00
99281	Emergency department visit for the evaluation and management, self-limited or minor	0%	12	$0.00
J3301	Injection, triamcinolone acetonide, not otherwise specified, 10 mg	0%	57	$0.00
90662		0%	23	$0.00
J3475	Injection, magnesium sulfate, per 500 mg	0%	50	$0.00
76942		0%	16	$0.00
74176	Computed tomography, abdomen and pelvis; without contrast material	0%	55	$0.00
96413	Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance	0%	16	$0.00
99393	Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years)	0%	14	$0.00
82248		0%	12	$0.00
99392	Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years)	0%	39	$0.00
59025	Fetal non-stress test	0%	12	$0.00
36600		0%	28	$0.00
J0702	Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg	0%	13	$0.00
94726		0%	13	$0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialHICKEY-BOYNTON, MARGARET (CFO)